Infective endocarditis in chronic haemodialysis patients: An increasing clinical challenge

European Heart Journal

Volumn 28, Issue 19, 2007, Pages 2307-2312

  Nucifora, Gaetano ^a   Badano, Luigi P ^a   Viale, Pierluigi ^a   Gianfagna, Pasquale ^a   Allocca, Giuseppe ^a   Montanaro, Domenico ^a   Livi, Ugolino ^a   Fioretti, Paolo M ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Cardiac surgery; Echocardiography; Haemodialysis; Infective endocarditis; Prognosis

Indexed keywords

CEFAZOLIN; DAPTOMYCIN; LINEZOLID; OXACILLIN; RIFAMPICIN; VANCOMYCIN; WARFARIN;

ABSENCE OF SIDE EFFECTS; ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BLEEDING; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DRUG BLOOD LEVEL; ECHOCARDIOGRAPHY; HEART VALVE PROSTHESIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; INFECTION RISK; KIDNEY FAILURE; MICROBIOLOGICAL EXAMINATION; MORBIDITY; MORTALITY; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SURGICAL MORTALITY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT INDICATION;

ENDOCARDITIS, BACTERIAL; HUMANS; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS;

EID: 35148878268     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm278     Document Type: Review

References (53)

1. McCarthy JT, Steckelberg JM. Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc 2000;75:1008-1014.
2. Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966;275:1089-1092.
3. Abbott KC, Agodoa LY. Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States. Nephron 2002;91:203-209.
4. Maraj S, Jacobs LE, Kung SC, Raja R, Krishnasamy P, Maraj R, Braitman LE, Kotler MN. Epidemiology and outcome of infective endocarditis in hemodialysis patients. Am J Med Sci 2002;324:254-260.
5. Moreillon P, Que YA. Infective endocarditis. Lancet 2004;363:139-149.
6. Hoen B. Infective endocarditis: a frequent disease in dialysis patients. Nephrol Dial Transplant 2004;19:1360-1362.
7. Lamas CC, Eykyn SJ. Hospital acquired native valve endocarditis: analysis of 22 cases presenting over 11 years. Heart 1998;79:442-447.
8. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, Woods CW, Reller LB, Ryan T, Fowler VG Jr. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002;162:90-94.
9. Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch F. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002;288:75-81.
10. Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, Levison ME, Korzeniowski OM, Kaye D. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation 2000;102:2842- 2848.
11. Umana E, Ahmed W, Alpert MA. Valvular and perivalvular abnormalities in end-stage renal disease. Am J Med Sci 2003;325:237-242.
12. Fishbein MC, Gissen SA, Collins JJ Jr, Barsamian EM, Cohn LH. Pathologic findings after cardiac valve replacement with glutaraldehyde-fixed porcine valves. Am J Cardiol 1977;40:331-337.
13. Madu EC, D'Cruz IA, Wall B, Mansour N, Shearin S. Transesophageal echocardiographic spectrum of calcific mitral abnormalities in patients with end-stage renal disease. Echocardiography 2000;17:29-35.
14. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 1999;55:1081-1090.
15. Sexton DJ. Vascular access infections in patients undergoing dialysis with special emphasis on the role and treatment of Staphylococcus aureus. Infect Dis Clin North Am 2001;15:731-742. vii.
16. Stevenson KB, Adcox MJ, Mallea MC, Narasimhan N, Wagnild JP. Standardized surveillance of hemodialysis vascular access infections: 18-month experience at an outpatient, multifacility hemodialysis center. Infect Control Hosp Epidemiol 2000;21:200-203.
17. Fernandez-Cean J, Alvarez A, Burguez S, Baldovinos G, Larre-Borges P, Cha M. Infective endocarditis in chronic haemodialysis: two treatment strategies. Nephrol Dial Transplant 2002;17:2226-2230.
18. Maraj S, Jacobs LE, Maraj R, Kotler MN. Bacteremia and infective endocarditis in patients on hemodialysis. Am J Med Sci 2004;327:242-249.
19. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005;5:751-762.
20. Engemann JJ, Friedman JY, Reed SD, Griffiths RI, Szczech LA, Kaye KS, Stryjewski ME, Reller LB, Schulman KA, Corey GR, Fowler VG Jr. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 2005;26:534-539.
21. Troidle L, Eisen T, Pacelli L, Finkelstein F. Complications associated with the development of bacteremia with Staphylococcus aureus. Hemodial Int 2007;11:72-75.
22. Doulton T, Sabharwal N, Cairns HS, Schelenz S, Eykyn S, O'Donnell P, Chambers J, Austen C, Goldsmith DJ. Infective endocarditis in dialysis patients: new challenges and old. Kidney Int 2003;64:720-727.
23. Spies C, Madison JR, Schatz IJ. Infective endocarditis in patients with end-stage renal disease: clinical presentation and outcome. Arch Intern Med 2004;164:71-75.
24. Nori US, Manoharan A, Thornby JI, Yee J, Parasuraman R, Ramanathan V. Mortality risk factors in chronic haemodialysis patients with infective endocarditis. Nephrol Dial Transplant 2006;21:2184-2190.
25. Fowler VG Jr, McIntyre LM, Yeaman MR, Peterson GE, Barth RL, Corey GR, Wray D, Bayer AS. In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J Infect Dis 2000;182:1251-1254.
26. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994;96:200-209.
27. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-638.
28. Vijayvargiya R, Veis JH. Antibiotic-resistant endocarditis in a hemodialysis patient. J Am Soc Nephrol 1996;7:536-542.
29. Wu EB, Witherspoon ML, Gillmore JD, Pattison JM, Chambers JB. The role of transesophageal echocardiography in patients with chronic renal failure at low and high risk of endocarditis. J Heart Valve Dis 1997;6:249-252.
30. Ruiz M, Sanchez MP, Dominguez JC, Pineda SO, Penas ER, Rubio MD, Ortega MD, Belsue FV. Infective endocarditis in patients receiving chronic hemodialysis: clinical features and outcome. J Heart Valve Dis 2005;14:11-14.
31. Shroff GR, Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients with bacterial endocarditis in the United States. Am J Kidney Dis 2004;44:1077-1082.
32. d'Udekem Y, David TE, Feindel CM, Armstrong S, Sun Z. Long-term results of surgery for active infective endocarditis. Eur J Cardiothorac Surg 1997;11:46-52.
33. Alexiou C, Langley SM, Stafford H, Lowes JA, Livesey SA, Monro JL. Surgery for active culture-positive endocarditis: determinants of early and late outcome. Ann Thorac Surg 2000;69:1448-1454.
34. Bauernschmitt R, Jakob HG, Vahl CF, Lange R, Hagl S. Operation for infective endocarditis: results after implantation of mechanical valves. Ann Thorac Surg 1998;65:359-364.
35. Aksoy O, Sexton DJ, Wang A, Pappas PA, Kourany W, Chu V, Fowler VG Jr, Woods CW, Engemann JJ, Corey GR, Harding T, Cabell CH. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis 2007;44:364-372.
36. EBPG Expert Group on Renal Transplantation. European Best Practice Guidelines for Renal Transplantation (part 1). Nephrol Dial Transplant 2000;15(Suppl. 7):1-85.
37. Nassar GM, Ayus JC. Infectious complications of old nonfunctioning arteriovenous grafts in renal transplant recipients: a case series. Am J Kidney Dis 2002;40:832-836.
38. The Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Infect Control Hosp Epidemiol 1995;16:105-113.
39. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999;340:493-501.
40. Kitzis MD, Goldstein FW. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections. Clin Microbiol Infect 2006;12:92-95.
41. Pea F, Viale P. The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients? Clin Infect Dis 2006;42:1764-1771.
42. Wang G, Hindler JF, Ward KW, Bruckner DA. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol 2006;44:3883-3886.
43. Drees M, Boucher H. New agents for Staphylococcus aureus endocarditis. Curr Opin Infect Dis 2006;19:544-550.
44. Lentino JR, Baddour LM, Wray M, Wong ES, Yu VL. Staphylococcus aureus and other bacteremias in hemodialysis patients: antibiotic therapy and surgical removal of access site. Infection 2000;28:355-360.
45. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997;127:275-280.
46. Capdevila JA, Segarra A, Pahissa A. Catheter-related bacteremia in patients undergoing hemodialysis. Ann Intern Med 1998;128:600.
47. Mokrzycki MH, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant 2006;21:1024-1031.
48. Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, Soler-Soler J, Thiene G, von Graevenitz A, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Fernandez BE, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Lekakis J, Vahanian A, Delahaye F, Parkhomenko A, Filipatos G, Aldershvile J, Vardas P. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 2004;25:267-276.
49. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394-e434.
50. Horstkotte D, Piper C. Chronic hemodialysis: high risk for manifestation of infective endocarditis with poor outcome. J Heart Valve Dis 2005;14:8-10.
51. Lucke JC, Samy RN, Atkins BZ, Silvestry SC, Douglas JM Jr, Schwab SJ, Wolfe WG, Glower DD. Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients. Ann Thorac Surg 1997;64:129-132.
52. Kaplon RJ, Cosgrove DM III, Gillinov AM, Lytle BW, Blackstone EH, Smedira NG. Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival. Ann Thorac Surg 2000;70:438-441.
53. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989;87:144-152.